Want to see HK:1255 full AI Analyst Report?
TATA Health International Holdings Ltd. (1255) AI Stock Analysis
Top Page
TATA Health International Holdings Ltd.
(HKEX:1255)
The score is primarily driven by weak financial performance—negative equity, uneven earnings quality, and negative operating/free cash flow in 2025. Technicals add pressure with a below-moving-average setup and negative MACD, while valuation is constrained by a negative P/E and no dividend support.
TATA Health International Holdings Ltd. (1255) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 443.19M
- Dividend Yield
- ―
- Average Volume (3M)
- 19.79K
- Price to Earnings (P/E)
- -58.9
- Beta (1Y)
- 0.34
- Revenue Growth
- 11.34%
- EPS Growth
- 82.34%
- Country
- Hong Kong
- Employees
- 107
- Sector
- Consumer Cyclical
- Sector Strength
- 61
- Industry
- Apparel - Footwear & Accessories
TATA Health International Holdings Ltd. Business Overview & Revenue Model
Company Description
TATA Health International Holdings Limited functions as an investment holding company with diverse business interests, including the sale of footwear and healthcare goods, in addition to offering financial and online medical services. Its operations...
TATA Health International Holdings Ltd. Financial Statement Overview
Summary
Financial quality is high risk: negative shareholders’ equity in 2024–2025, inconsistent profitability with weak/negative operating performance in most years, and cash generation deteriorating to negative operating and free cash flow in 2025 despite a return to net profit.
Income Statement
34NegativeBalance Sheet
18Very NegativeCash Flow
22Negative| Breakdown | TTM | Dec 2025 | Jun 2025 | Dec 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 104.96M | 99.80M | 207.54M | 124.45M | 144.61M | 160.93M |
| Gross Profit | 76.40M | 80.26M | 150.76M | 84.95M | 113.94M | 104.72M |
| EBITDA | -3.05M | -11.64M | -20.22M | -39.32M | 18.61M | -49.54M |
| Net Income | -7.54M | 13.35M | -32.29M | -68.34M | 9.61M | -60.76M |
Balance Sheet | ||||||
| Total Assets | 97.41M | 91.12M | 182.11M | 135.19M | 176.05M | 176.86M |
| Cash, Cash Equivalents and Short-Term Investments | 10.43M | 17.92M | 40.00M | 23.00M | 33.65M | 47.03M |
| Total Debt | 32.63M | 25.87M | 54.41M | 35.91M | 51.03M | 52.68M |
| Total Liabilities | 153.26M | 145.56M | 198.28M | 191.37M | 157.12M | 163.26M |
| Stockholders Equity | -55.02M | -54.44M | 1.72M | -64.45M | 33.65M | 23.01M |
Cash Flow | ||||||
| Free Cash Flow | -26.43M | -22.40M | 0 | -3.56M | 12.12M | -5.97M |
| Operating Cash Flow | -20.88M | -18.59M | 0 | 1.24M | 13.01M | -4.90M |
| Investing Cash Flow | -12.50M | 15.12M | 0 | -2.10M | 7.93M | -39.81M |
| Financing Cash Flow | 6.41M | -1.61M | 0 | -15.70M | -13.96M | 43.24M |
TATA Health International Holdings Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1255, the sentiment is Negative. The current price of 1.82 is below the 20-day moving average (MA) of 1.86, below the 50-day MA of 1.97, and below the 200-day MA of 2.05, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 25.97 is Positive, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1255.
TATA Health International Holdings Ltd. Peers Comparison
Overall Rating
HK:183673Outperform
HK:055171.75Outperform
HK:136168Neutral
HK:021067Neutral
HK:102847Neutral- HK:125540Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:1836 | 73Outperform | HKD 11.01B | 11.21 | 11.35% | 10.32% | 2.33% | -22.20% |
| HK:0551 | 72Outperform | HKD 21.96B | 7.27 | 6.60% | 9.49% | -3.17% | -24.14% |
| HK:1361 | 68Neutral | HKD 10.13B | 6.01 | 12.73% | 7.16% | 13.07% | 17.56% |
| HK:0210 | 67Neutral | HKD 573.68M | 5.04 | 11.96% | 6.90% | 1.49% | -9.08% |
| Sector * | 61Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
| HK:1028 | 47Neutral | HKD 1.64B | -509.12 | -0.12% | ― | -7.94% | 99.47% |
| HK:1255 | 40Underperform | HKD 443.19M | -58.87 | 13.77% | ― | 11.34% | 82.34% |
* Consumer Cyclical Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1255 | TATA Health International Holdings Ltd. | 1.82 | 1.52 | 508.33% | |
| HK:0210 | Daphne International Holdings | 0.29 | -0.11 | -27.86% | |
| HK:1836 | Stella International Holdings | 13.08 | -2.02 | -13.38% | |
| HK:1361 | 361 Degrees International | 4.67 | -0.82 | -14.91% | |
| HK:0551 | Yue Yuen Industrial (Holdings) | 13.70 | 0.66 | 5.09% | |
| HK:1028 | C.banner International Holdings Ltd. | 0.66 | -0.19 | -22.35% |
TATA Health International Holdings Ltd. Corporate Events
TATA Health Swings to Interim Loss on Margin Squeeze and Lower Other Gains
TATA Health International Holdings Ltd. reported interim results for the six months ended 30 June 2026 showing a slight revenue decline to HK$47.3 million from HK$49.5 million and a sharp drop in gross profit as margin fell from 85.3% to 65.5%. The g...
TATA Health Sharply Scales Back Expected Interim Loss After Profit Warning Clarification
TATA Health International Holdings Ltd. has issued a clarification to its earlier profit warning for the six months ended 30 June 2026, after a post-issuance review of unaudited consolidated financial statements uncovered minor clerical inaccuracies....
TATA Health Issues Profit Warning on Interim Loss After One-Off Gain Falls Away
TATA Health International Holdings Limited has warned that it expects to report a loss attributable to shareholders of about HK$12.4 million for the six months ended 30 June 2026, compared with a profit of roughly HK$20.6 million a year earlier. The...
TATA Health Faces Winding-Up Petition Over Former Director’s Pay Dispute
TATA Health International Holdings Ltd. has disclosed that a former independent non-executive director, Tao Chi Keung, has filed a winding-up petition in the Hong Kong High Court over an unpaid director’s emolument claim of HK$139,150.68. The c...
TATA Health Schedules Board Meeting to Review Interim Results and Dividend
TATA Health International Holdings Limited has scheduled a board meeting for 28 August 2026 to review and approve the unaudited financial results for the six months ended 30 June 2026. The board will also consider the declaration of an interim divide...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 23, 2026